Mitoxantrone 61703-0343-65

Package NDC

61703-0343-65

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 11, 2006
Listing Expires: December 31, 2026
Application: ANDA076871

Need to source Mitoxantrone? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Mitoxantrone Hydrochloride	2 mg/mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

61703-0343-65Selected

1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-65) / 12.5 mL in 1 VIAL, MULTI-DOSE

Other packages for this product(2)

61703-0343-18

1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18) / 10 mL in 1 VIAL, MULTI-DOSE

View →

61703-0343-66

1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-66) / 15 mL in 1 VIAL, MULTI-DOSE

View →